Neurocrine Biosciences

Our Company

Neurocrine Biosciences of San Diego discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.

In the News
12/10/2014 Neurocrine Biosciences Announces Expansion of its Clinical Pipeline
12/4/2014 Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference view all press releases


Webcast Webcast

Neurocrine frequently conducts webcasts and conference calls to provide presentations and company updates and progress on research and development activiites.

 view current webcasts 



New Data Our Corporation Presentation

This presentation provides an overview of our company pipeline, program process, and financial highlights.

/common/images/orangearrow.gif view the presentation



Stock Quote
Price Quote 24.49
Change 0.59
(20 minutes delayed)
 
Date
12/19/2014
Time
4:00 pm